Structures by: Baryala Y.
Total: 7
Ethyl 3-methyl-1-oxo-4<i>H</i>-1,4-benzothiazine-2-carboxylate monohydrate
C12H13NO3S,H2O
IUCrData (2018) 3, 6 x180887
a=8.8340(3)Å b=18.6849(6)Å c=7.6927(3)Å
α=90° β=91.4780(10)° γ=90°
1-(1,3-Benzothiazol-2-yl)propan-2-ol
C10H11NOS
Acta Crystallographica Section E (2005) 61, 9 o3027-o3029
a=15.7702(11)Å b=7.8856(4)Å c=15.8703(11)Å
α=90° β=101.135(5)° γ=90°
Methyl 2-oxo-2,3-dihydro-1,3-benzothiazole-3-acetate
C10H9NO3S
Acta Crystallographica Section E (2005) 61, 11 o3872-o3873
a=4.7858(3)Å b=12.4010(7)Å c=17.5319(10)Å
α=90° β=95.679(5)° γ=90°
Ethyl 3-methyl-1-oxo-4H-1,4-benzothiazine-2-carboxylate
C12H13NO3S
Acta Crystallographica Section E (2005) 61, 8 o2716-o2717
a=12.9935(13)Å b=33.042(4)Å c=11.1555(13)Å
α=90° β=90° γ=90°
4-[(3-Hydroxy-5-phenyl-1H-pyrazol-4-yl)methyl]-5-phenyl-1H-pyrazol-3(2H)-one
C19H16N4O2
Acta Crystallographica Section E (2007) 63, 5 o2554-o2556
a=9.2908(10)Å b=16.4731(15)Å c=11.0153(13)Å
α=90.00° β=106.903(8)° γ=90.00°
Dimethyl 3-acetyl-3-(1,3-benzothiazol-2-yl)pentanedioate
C16H17NO5S
Acta Crystallographica Section E (2008) 64, 12 o2290
a=14.4075(3)Å b=8.8089(2)Å c=13.8968(3)Å
α=90.00° β=118.0110(10)° γ=90.00°
3-(Benzothiazol-2-yl)-3-(prop-2-ynyl)hex-5-yn-2-one
C16H13NOS
Acta Crystallographica Section E (2010) 66, 4 o857
a=7.79130(10)Å b=30.2051(6)Å c=12.4437(2)Å
α=90.00° β=106.1610(10)° γ=90.00°